Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Abacus Medicine A/S

02 3Janssen - Cilag International

03 3Janssen-Cilag Ag

04 10Janssen-Cilag International N.V.

05 3Janssen-Cilag International NV

06 5Janssen-Cilag International Nv

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Daratumumab

Brand Name : Darzalex

Dosage Form : Injectable Solution

Dosage Strength : 1800mg

Packaging :

Approval Date : 03/06/2020

Application Number : 20190724000043

Regulatory Info : Approved

Registration Country : Sweden

blank

02

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Daratumumab

Brand Name : Darzalex

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 20mg/ml

Packaging :

Approval Date : 20/05/2016

Application Number : 20150911000058

Regulatory Info : Approved

Registration Country : Sweden

blank

03

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Daratumumabum

Brand Name : Darzalex

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 100mg/5ml

Packaging :

Approval Date : 06/12/2016

Application Number : 66072

Regulatory Info : Allowed

Registration Country : Switzerland

blank

04

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Daratumumabum

Brand Name : Darzalex

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 400mg/20ml

Packaging :

Approval Date : 06/12/2016

Application Number : 66072

Regulatory Info : Allowed

Registration Country : Switzerland

blank

05

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Daratumumabum

Brand Name : DARZALEX SC

Dosage Form : Solution For Injection

Dosage Strength : 1800mg/15ml

Packaging :

Approval Date : 13/08/2020

Application Number : 67689

Regulatory Info : Allowed

Registration Country : Switzerland

blank

06

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Daratumumab

Brand Name : Darzalex®

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 20mg/ml

Packaging :

Approval Date : 19-11-2020

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

07

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Daratumumab

Brand Name : Darzalex®

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 20mg/ml

Packaging :

Approval Date : 19-11-2020

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

08

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Daratumumab

Brand Name : Darzalex®

Dosage Form : Injectable Solution

Dosage Strength :

Packaging :

Approval Date : 03-02-2025

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

09

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Daratumumab

Brand Name : Darzalex

Dosage Form : Solution For Injection

Dosage Strength : 1800mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

10

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Daratumumab

Brand Name : Darzalex

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 20mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank